- Home
- MFA vs KOD Comparison
MFA vs KOD Comparison
Compare MFA & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFA
- KOD
- Stock Information
- Founded
- MFA 1997
- KOD 2009
- Country
- MFA United States
- KOD United States
- Employees
- MFA N/A
- KOD N/A
- Industry
- MFA Real Estate Investment Trusts
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MFA Real Estate
- KOD Health Care
- Exchange
- MFA Nasdaq
- KOD Nasdaq
- Market Cap
- MFA 930.2M
- KOD 795.5M
- IPO Year
- MFA N/A
- KOD 2018
- Fundamental
- Price
- MFA $8.98
- KOD $16.87
- Analyst Decision
- MFA Buy
- KOD Buy
- Analyst Count
- MFA 7
- KOD 7
- Target Price
- MFA $11.00
- KOD $19.29
- AVG Volume (30 Days)
- MFA 1.1M
- KOD 964.2K
- Earning Date
- MFA 11-06-2025
- KOD 11-13-2025
- Dividend Yield
- MFA 16.05%
- KOD N/A
- EPS Growth
- MFA N/A
- KOD N/A
- EPS
- MFA 0.86
- KOD N/A
- Revenue
- MFA $274,911,000.00
- KOD N/A
- Revenue This Year
- MFA N/A
- KOD N/A
- Revenue Next Year
- MFA $14.85
- KOD N/A
- P/E Ratio
- MFA $10.43
- KOD N/A
- Revenue Growth
- MFA N/A
- KOD N/A
- 52 Week Low
- MFA $7.85
- KOD $1.92
- 52 Week High
- MFA $12.60
- KOD $21.17
- Technical
- Relative Strength Index (RSI)
- MFA 42.09
- KOD 51.12
- Support Level
- MFA $8.80
- KOD $17.04
- Resistance Level
- MFA $9.26
- KOD $19.26
- Average True Range (ATR)
- MFA 0.17
- KOD 1.86
- MACD
- MFA 0.02
- KOD -0.27
- Stochastic Oscillator
- MFA 35.87
- KOD 17.86
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.